메뉴 건너뛰기




Volumn 16, Issue 1, 1998, Pages 139-144

Interpreting the significance of changes in health-related quality-of- life scores

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; NAVELBINE;

EID: 0031972496     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.139     Document Type: Article
Times cited : (2475)

References (11)
  • 1
    • 0027200353 scopus 로고
    • Interpretation of quality of life changes
    • Lydick E, Epstein RS: Interpretation of quality of life changes. Qual Life Res 2:221-226, 1993
    • (1993) Qual Life Res , vol.2 , pp. 221-226
    • Lydick, E.1    Epstein, R.S.2
  • 2
    • 0024852022 scopus 로고
    • Measurement of health status. Ascertaining the minimal clinically important difference
    • Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10:407-415, 1989
    • (1989) Control Clin Trials , vol.10 , pp. 407-415
    • Jaeschke, R.1    Singer, J.2    Guyatt, G.H.3
  • 3
    • 0028055059 scopus 로고
    • Determining a minimal important change in a disease-specific quality of life questionnaire
    • Juniper EF, Guyatt GH, Willan A, et al: Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 47:81-87, 1994
    • (1994) J Clin Epidemiol , vol.47 , pp. 81-87
    • Juniper, E.F.1    Guyatt, G.H.2    Willan, A.3
  • 4
    • 0000318934 scopus 로고    scopus 로고
    • A phase III comparative study of vinorelbine (VNB) combined with doxorubicin (DOX) versus doxorubicin alone in metastatic/recurrent breast cancer (MBC): A National Cancer Institute of Canada (NCIC CTG) study
    • abstr
    • Norris B, Pritchard K, James K, et al: A phase III comparative study of vinorelbine (VNB) combined with doxorubicin (DOX) versus doxorubicin alone in metastatic/recurrent breast cancer (MBC): A National Cancer Institute of Canada (NCIC CTG) study. Proc Am Soc Clin Oncol 15:59, 1996 (abstr)
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 59
    • Norris, B.1    Pritchard, K.2    James, K.3
  • 5
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30; A quality-of-life instrument for use in international clinical trials in oncology
    • Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30; A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 10
    • 0030471590 scopus 로고    scopus 로고
    • The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30
    • King MT: The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5:555-567, 1996
    • (1996) Qual Life Res , vol.5 , pp. 555-567
    • King, M.T.1
  • 11
    • 0027081733 scopus 로고
    • Reporting the size of the effects in research studies to facilitate assessment of practical or clinical significance
    • Kraemer HC: Reporting the size of the effects in research studies to facilitate assessment of practical or clinical significance. Psychoneuroendocrinal 17:527-536, 1992
    • (1992) Psychoneuroendocrinal , vol.17 , pp. 527-536
    • Kraemer, H.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.